Retractable Technologies, Inc. (RVP)

US — Healthcare Sector
Peers: OSUR  TEVNF  MLSS  STSS  PRTS  IMDX  APT  INFU 

Automate Your Wheel Strategy on RVP

With Tiblio's Option Bot, you can configure your own wheel strategy including RVP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol RVP
  • Rev/Share 0.8501
  • Book/Share 2.5591
  • PB 0.2657
  • Debt/Equity 0.0045
  • CurrentRatio 6.7027
  • ROIC -0.2604

 

  • MktCap 20354302.0
  • FreeCF/Share -0.4112
  • PFCF -1.6534
  • PE -0.8921
  • Debt/Assets 0.0023
  • DivYield 0
  • ROE -0.2743

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 5
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
RVP
Published: June 30, 2025 by: Business Wire
Sentiment: Neutral

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2025 through June 30, 2025. The dividends will be paid on July 21, 2025 to shar.

Read More
image for news Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Zacks Initiates Coverage of Retractable Technologies With Underperform Recommendation
RVP
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Negative

Discover why Zacks rates Retractable Technologies as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore RVP's declining profitability amid rising costs, significant cash concerns and concentration risk.

Read More
image for news Zacks Initiates Coverage of Retractable Technologies With Underperform Recommendation

About Retractable Technologies, Inc. (RVP)

  • IPO Date 2001-05-04
  • Website https://www.retractable.com
  • Industry Medical - Instruments & Supplies
  • CEO Thomas J. Shaw
  • Employees 221
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.